Sleep disorder clinical trials update

Zelda Therapeutics Enters Into Collaboration Agreement with Prestigious Telethon Kids Institute

Significant Anti-Cancer Effect Observed in Pre-Clinical Studies

Zelda Expands Intellectual Property Portfolio

Zelda Therapeutics debuts on ASX

Investor Presentation Nov 2016

19 Jan 2016 – Q&A Proactive Investors

Gleneagle Gold (ASX:GLN) has positioned itself to transition into the medical cannabis sector after entering into an agreement in relation to acquiring 100% of the issued capital of Zelda Therapeutics Pty Ltd. 09 Dec 2015 – Q&A Proactive Investors